Why is Caplin Point Lab falling/rising?

As of 07-Nov, Caplin Point Laboratories Ltd is experiencing a decline in its stock price, currently at Rs 1,949.00, which reflects a decrease of Rs 54.65 or 2.73%. Today's price summary indicates that the stock has underperformed its sector by 2.39%, with an intraday low of Rs 1,896, marking a drop of 5.37%. The stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a bearish trend. Despite this, there has been a notable increase in investor participation, with delivery volume rising by 68.07% against the 5-day average. The stock has shown a negative performance over the past week and month, with returns of -4.14% and -2.38%, respectively, while it has significantly underperformed year-to-date with a decline of 22.09%.
In the broader market context, the Sensex has shown a relatively stable performance, gaining 1.57% over the past month, which contrasts with Caplin Point's negative returns. This divergence highlights the stock's struggles in the current market environment. However, it is important to note that the company has demonstrated high management efficiency with a return on equity of 16.38% and has maintained a low debt-to-equity ratio. Additionally, Caplin Point has reported positive results for the last 13 consecutive quarters, indicating strong operational cash flow and net sales. Despite these positive factors, the stock's recent performance reflects broader market pressures and investor sentiment, contributing to its current decline.